Related references
Note: Only part of the references are listed.Nephropathy in Type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity
Inge Tarnow et al.
PLATELETS (2009)
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria
Patrizia Ferroni et al.
CLINICAL SCIENCE (2008)
Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years - Association with mortality and decline of glomerular filtration rate
Anne Sofie Astrup et al.
DIABETES CARE (2008)
Increased concentrations of soluble CD40 ligand may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria
F. Chiarelli et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2008)
Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16
Benjamin A. Olenchock et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2008)
Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS)
KP Burdon et al.
AMERICAN HEART JOURNAL (2006)
Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease
PJ Mason et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
From hyperglycemia to diabetic kidney disease: The role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines
BF Schrijvers et al.
ENDOCRINE REVIEWS (2004)
Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization
MI Furman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus - Relationships to cardiovascular disease and risk factor intervention
HS Lim et al.
CIRCULATION (2004)
Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease
L Kairaitis et al.
KIDNEY INTERNATIONAL (2003)
Effects of candesartan on mortality and morbidity in patients with chronic heart failure:: the CHARM-Overall programme
MA Pfeffer et al.
LANCET (2003)
Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients -: A novel target of thiazolidinediones
N Varo et al.
CIRCULATION (2003)
Soluble CD40 ligand in acute coronary syndromes
C Heeschen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein-1 via the CD40/CD40 ligand pathway and may amplify glomerular injury
T Tanaka et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Soluble CD40L and cardiovascular risk in women
U Schönbeck et al.
CIRCULATION (2001)
Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro
R Assert et al.
DIABETOLOGIA (2001)
Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland
P Pajukanta et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Share Paper
